Navigation Links
New Lung Cancer Drug Launched By Roche Pharmaceutical

Major Pharmaceutical Company Roche launched its anti-cancer drug `Tarceva' (erlotinib), which `prolongs and improves' quality of life of patients//, suffering from lung cancer.

The Managing Director Dr G L Telang said, it was an oral tablet taken once a day and has the potential to treat many types of solid tumours therapy for patients with locally advanced or metastatic Non-Small Cell Lung Cancer (NSCLC) even after failure of at least one prior chemotherapy regiment.

Dr. Telang also said that, the drug has demonstrated a striking survival benefit (42.5 per cent) in advanced non-small cell lung cancer, the most common form of the disease and it has also shown to significantly improve patients' quality of life by reducing the severe and debilitating symptoms that characterise advanced disease, such as cough, pain and breathlessness.

Tarceva works differently to chemotherapy by specifically targeting tumour cells and inhibiting their growth. The drug blocks the tumour cell growth. It acts by inhibiting the activity of a specific enzyme, tyrosine kinase, which is part of the human epidermal growth receptor (EGFR).

Regarding the registration of the drug in the country, they have applied to the government for registration and expect it to come through by the end of this year, he said. Dr.Telang said that the drug will be sold 40 per cent below the international cost and if the government removes the duty on the drug, then the price will be further reduced. He also stated by using the drug, the life of the patient would extends up to a year.

Dr.Telang said, that they were also focusing on trials on earlier stages of NSCLC and in combination with another anti-cancer drug of Roche 'avastin. Trials are also being conducted with Tarceva in other solid tumours like ovarian, bronchioloalveolar and colorectal, head, neck and brain.


Page: 1

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:

(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... ... new set of retro-fused, self-animating trailer titles with ProTrailer: Vintage. This newly styled ... These classically-influenced trailer titles work with any font, giving users limitless opportunities to ...
(Date:11/26/2015)... ... ... Inc., developer and distributor of the world-class Asterisk based contact center software Q-Suite, announces ... new Q-Suite 6 platform is based on the latest Java Enterprise standards. By conforming ... of software for many key components of the suite. Much of the suite runs ...
(Date:11/25/2015)... ... November 25, 2015 , ... As part of a global ... attracts volunteers together who want to combine talents and resources to help create ... the process. The non-profit launched its first major fundraiser on November 6, 2015 ...
(Date:11/25/2015)... , ... November 25, 2015 , ... Finnleo, a leader ... Eve on several models of traditional and far-infrared saunas. , For traditional ... is the most traditional Finnish sauna wood, and Finnleo uses only European Grade A ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... offering factory direct sauna parts and accessories. , Sauna accessories help improve the ... bather’s style and personality. From basic styles for the purist looking for simplicity ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 ... addition of the  "2016 Future Horizons ... Cell Surface Testing Market: Supplier Shares, ... their offering.  --> ... the  "2016 Future Horizons and Growth ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... --> adds "Global ... and "Investigation Report on China Repaglinide ... 2021 forecasts data and information to ... . --> ...
(Date:11/25/2015)... 2015 ... "Global Brain Monitoring Devices Market 2015-2019" ... ) has announced the addition ... Market 2015-2019" report to their offering. ... ) has announced the addition of ...
Breaking Medicine Technology: